|
Home : Unsafe Drugs : Avandia : News Articles : Investors mobilize in fight to shake up the FDA - The Boston Globe Investors mobilize in fight to shake up the FDA - The Boston Globe
The National Venture Capital Association and medical device trade groups argue that the FDA, stung by high-profile safety controversies in recent years (stents, Vioxx, Avandia), has become so fixated on risks that it is stifling innovation in an industry where the United States has a competitive edge. FDA reviews of medical device applications, critics say, have become ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




